AIM insider transactions
AIM ImmunoTech Inc. (AIM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for AIM
- CEO & President Equels Thomas K converted options into 25,000 shares, increasing direct ownership by 64% to 63,922 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Chemerow David I. converted options into 25,000 shares, increasing direct ownership by 727% to 28,441 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- SEC Form 4 filed by AIM ImmunoTech Inc.4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- SEC Form 4 filed by AIM ImmunoTech Inc.4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Chemerow David I. was granted 2,800 shares (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- SEC Form 4 filed by Director Kellner Ted D4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Kellner Ted D bought $50,000 worth of shares (1,968,504 units at $0.03), increasing direct ownership by 196,850% to 1,969,504 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M bought $5,000 worth of shares (196,851 units at $0.03), increasing direct ownership by 61% to 521,723 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $50,000 worth of shares (1,968,504 units at $0.03), increasing direct ownership by 104% to 3,867,533 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $2,583 worth of shares (41,000 units at $0.06), increasing direct ownership by 2% to 1,899,029 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- COO, Secretary, Gen. Counsel Rodino Peter W Iii bought $44 worth of shares (500 units at $0.09), increasing direct ownership by 0.12% to 401,762 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M was granted 44,899 shares, increasing direct ownership by 16% to 324,872 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 44,899 shares, increasing direct ownership by 18% to 291,882 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Chemerow David I. was granted 44,899 shares, increasing direct ownership by 233% to 64,189 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $6,730 worth of shares (50,000 units at $0.13), increasing direct ownership by 3% to 1,858,029 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $5,060 worth of shares (44,000 units at $0.12), increasing direct ownership by 2% to 1,808,029 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Chemerow David I. was granted 19,290 shares (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M was granted 38,580 shares, increasing direct ownership by 16% to 279,973 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 38,580 shares, increasing direct ownership by 19% to 246,983 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $10,000 worth of shares (83,334 units at $0.12), increasing direct ownership by 5% to 1,764,029 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- SEC Form 3 filed by new insider Chemerow David I.3 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Amendment: Director Mitchell William M was granted 25,797 shares, increasing direct ownership by 15% to 198,063 units (SEC Form 4)4/A - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Amendment: Director Mitchell William M was granted 27,412 shares, increasing direct ownership by 19% to 172,266 units (SEC Form 4)4/A - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Amendment: Director Mitchell William M was granted 43,330 shares, increasing direct ownership by 22% to 241,393 units (SEC Form 4)4/A - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M gave a grant of 43,330 shares, decreasing direct ownership by 15% to 241,393 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 43,330 shares, increasing direct ownership by 26% to 208,403 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 25,797 shares, increasing direct ownership by 19% to 165,073 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M gave a grant of 25,797 shares, decreasing direct ownership by 12% to 198,063 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $4,240 worth of shares (20,000 units at $0.21), increasing direct ownership by 1% to 1,657,968 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M gave a grant of 27,412 shares, decreasing direct ownership by 14% to 172,226 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 27,412 shares, increasing direct ownership by 25% to 139,276 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 26,305 shares, increasing direct ownership by 31% to 111,864 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M was granted 26,305 shares, increasing direct ownership by 22% to 144,854 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Appelrouth Stewart was granted 8,768 shares, increasing direct ownership by 2% to 388,729 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- New insider Kellner Ted D claimed ownership of 1,583,000 shares (SEC Form 3)3 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M sold $884 worth of shares (4,580 units at $0.19), decreasing direct ownership by 4% to 118,549 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $4,682 worth of shares (22,727 units at $0.21), increasing direct ownership by 1% to 1,680,695 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M was granted 24,452 shares, increasing direct ownership by 25% to 123,803 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 24,452 shares, increasing direct ownership by 40% to 85,559 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Appelrouth Stewart was granted 24,452 shares, increasing direct ownership by 7% to 379,961 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Appelrouth Stewart bought $2,356 worth of shares (11,112 units at $0.21), increasing direct ownership by 3% to 355,509 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Mitchell William M was granted 22,645 shares, increasing direct ownership by 30% to 99,351 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Appelrouth Stewart was granted 22,645 shares, increasing direct ownership by 7% to 344,397 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Bryan Nancy was granted 22,645 shares, increasing direct ownership by 59% to 61,107 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $16,915 worth of shares (85,000 units at $0.20), increasing direct ownership by 5% to 1,637,968 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Director Appelrouth Stewart bought $15,817 worth of shares (81,953 units at $0.19), increasing direct ownership by 34% to 321,752 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $11,000 worth of shares (60,110 units at $0.18), increasing direct ownership by 4% to 1,552,968 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $1,515 worth of shares (5,000 units at $0.30), increasing direct ownership by 0.34% to 1,493,042 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K bought $6,160 worth of shares (20,000 units at $0.31), increasing direct ownership by 1% to 1,488,042 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K was granted 312,500 shares, increasing direct ownership by 27% to 1,468,042 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- COO, Secretary, Gen. Counsel Rodino Peter W Iii was granted 188,679 shares, increasing direct ownership by 89% to 401,262 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- CEO & President Equels Thomas K was granted 377,358 shares, increasing direct ownership by 48% to 1,155,542 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Equels Thomas K bought $25,000 worth of shares (61,729 units at $0.41), increasing direct ownership by 9% to 778,184 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Rodino Peter W Iii bought $12,500 worth of shares (30,865 units at $0.41), increasing direct ownership by 17% to 212,583 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- SEC Form 4 filed by Rodino Peter W Iii4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- SEC Form 4 filed by Equels Thomas K4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Bryan Nancy bought $15,000 worth of shares (38,462 units at $0.39) (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Equels Thomas K bought $25,000 worth of shares (75,758 units at $0.33), increasing direct ownership by 12% to 716,455 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Rodino Peter W Iii bought $12,500 worth of shares (37,879 units at $0.33), increasing direct ownership by 26% to 181,718 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)
- Appelrouth Stewart bought $30,000 worth of shares (90,910 units at $0.33), increasing direct ownership by 61% to 239,765 units (SEC Form 4)4 - AIM ImmunoTech Inc. (0000946644) (Issuer)